首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺心病急性加重期应用疏血通注射液的疗效分析
引用本文:张舒岩,及志勇,雷宇,姜晓明,张舒石.肺心病急性加重期应用疏血通注射液的疗效分析[J].中国热带医学,2010,10(9):1122-1123.
作者姓名:张舒岩  及志勇  雷宇  姜晓明  张舒石
作者单位:1. 吉林大学第一医院,吉林,长春,130031
2. 长春市人民医院,吉林,长春,130021
摘    要:目的观察对肺性心脏病急性加重期患者应用疏血通注射液后疗效。方法对收治的40例慢性肺源性心脏病急性加重期患者随机分为治疗组和对照组,对照组20例给予常规治疗,治疗组20例在常规治疗的基础上加用疏血通注射液,两组疗程为14d,在治疗前后分别对患者进行血液流变学检测。结果治疗前肺心病患者血液流变学指标明显异常,疏血通注射液治疗后血液流变学指标显著降低,心肺功能有明显改善,差异有统计学意义(P〈0.05)。结论疏血通注射液治疗肺心病急性加重期疗效确切,明显改善患者血液流变学,降低D-二聚体、全血高切粘度、低切粘度和高纤维蛋白原,改善患者预后。

关 键 词:疏血通  肺心病  血液流变学

Effect of Shuxuetong injection on pulmonary heart disease of acute and aggressive phase
Institution:ZHANG Shu-yan,JI Zhi-yong,LEI Yu,et al.(The First Hospital of Jilin University,Changchun 130031,Jilin,P.R.China)
Abstract:Aim To observe the therapeutic effects of Shuxuetong injection on patients with pulmonary heart disease of acute and aggressive phase.Methods The 40 patients with pulmonary heart disease of acute and aggressive phase were divided into treatment group and control group,each consisted of 20 cases.The control group were given routine treatment,the treatment group was given Shuxuetong injection in addition to the routine treatment.Results The hemorheological indicators in treatment group were significantly decreased after use of Shuxuetong(P0.05).Conclusion Shuxuetong injection is effective on patients with pulmonary heart disease of acute and aggressive phase.
Keywords:Shuxuetong  Pulmonary heart disease  Hemorheology
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号